Global Autism Spectrum Disorder Market Growth (Status and Outlook) 2025-2031

Global Autism Spectrum Disorder Market Growth (Status and Outlook) 2025-2031

The global Autism Spectrum Disorder market size is predicted to grow from US$ 9424 million in 2025 to US$ 11600 million in 2031; it is expected to grow at a CAGR of 3.5% from 2025 to 2031.

Autism spectrum disorder is a biologically based neurodevelopmental disorder characterized by persistent deficits in social communication and social interaction and restricted, repetitive patterns of behavior, interests and activities. Diagnosing autism spectrum disorder (ASD) can be difficult, since there is no medical test, like a blood test, to diagnose the disorders. Doctors look at the child’s behavior and development to make a diagnosis. Our report studies the market from 2014-2025, examining programs and medications used to the patient with autism.

Symptoms and Signs

Autism spectrum disorders may manifest during the first year of life but, depending on severity of symptoms, diagnosis may not be clear until school age.

Two main features characterize autism spectrum disorders:

Persistent deficits in social communication and interaction

Restricted, repetitive patterns of behavior, interests, and/or activities

Both of these features must be present at a young age (although they may not be recognized at the time) and must be severe enough to significantly impair the child"s ability to function at home, school, or other situations. Manifestations must be more pronounced than expected for the child’s developmental level and adjusted for norms in different cultures.

Industry concentration is relatively low. The revenue market share of Otsuka is about 6%. The other competitors include AstraZeneca, Pfizer, Eli Lilly and Johnson & Johnson among others.

In terms of type, Autistic Disorder occupied a larger market share, Autistic Disorder occupied 35% market share in global Autism Spectrum Disorder Diagnosis and Therapeutics market.

LPI (LP Information)' newest research report, the “Autism Spectrum Disorder Industry Forecast” looks at past sales and reviews total world Autism Spectrum Disorder sales in 2024, providing a comprehensive analysis by region and market sector of projected Autism Spectrum Disorder sales for 2025 through 2031. With Autism Spectrum Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Autism Spectrum Disorder industry.

This Insight Report provides a comprehensive analysis of the global Autism Spectrum Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Autism Spectrum Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Autism Spectrum Disorder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Autism Spectrum Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Autism Spectrum Disorder.

This report presents a comprehensive overview, market shares, and growth opportunities of Autism Spectrum Disorder market by product type, application, key players and key regions and countries.

Segmentation by Type:
Autistic Disorder
Asperger Syndrome
Childhood Disintegrative Disorder
Others

Segmentation by Application:
Children and Teenagers
Adults

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Otsuka
AstraZeneca
Pfizer
Eli Lilly
Johnson & Johnson

Please note: The report will take approximately 2 business days to prepare and deliver.